2000017

Modelling the impact and incremental cost-effectiveness of introducing vaccines against hepatitis B, haemophilus influenza type b and rotravirus into routine infant immunization programmes in Bangladesh and Peru

Short Title Cost effectiveness of adding new vaccine in EPI
Protocol No 2000017
Status Completed
Keywords VACCINE, HAEMOPHILUS INFLUENZA TYPE B, COST-EFFECTIVENESS OF VACCINE PREVENTABLE DISEASE, MARKOV MODELS, COST-EFFECTIVENESS, HEPATITIS B, DEVELOPING COUNTRIES, ROTAVIRUS
Center Public Health Sciences
MDG(s) this protocol relates to
HPNSDP(s) this protocol relates to
PI Name Md. Shahadat Hossain
Collaborating Institutes (056) Instituto de Investigacion Nutricional, Lima
(070) London School of Hygiene and Tropical Medicine (LSHTM)
(088) National Institutes of Health (NIH), Bethesda
(130) Tulane University, New Orleans
Funding
Summary
‹ Search All Protocols Here